摘要:
Novel proteins which have a molecular weight of about 42,000 daltons and have at the N terminus the amino acid sequenceXaa Thr Pro Tyr Ala Pro Glu Pro Gly Set Thr Cys Arg Leu Arg Gluwhere X is hydrogen, a phenylalanine residue (Phe) or the amino acid sequences Ala Phe, Val Ala Phe, Gln Val Ala Phe, Ala Gln Val Ala Phe, Pro Ala Gln Val Ala Phe or Leu Pro Ala Gln Val Ala Phe, and which are suitable for the treatment of diseases, are described.
摘要翻译:PCT No.PCT / EP90 / 00719 Sec。 371日期1991年9月26日 102(e)1991年9月26日PCT PCT 1990年5月4日PCT公布。 第WO90 / 13575号公报 日期:1990年11月15日。分子量为约42,000道尔顿且在N末端具有氨基酸序列的新型蛋白质Xaa Thr Pro Tyr Ala Pro Glu Pro Gly Set Thr Cys Arg Leu Arg Glu,其中X为氢, 苯丙氨酸残基(Phe)或氨基酸序列Ala Phe,Val Ala Phe,Gln Val Ala Phe,Ala Gln Val Ala Phe,Pro Ala Gln Val Ala Phe或Leu Pro Ala Gln Val Ala Phe,适用于治疗 的疾病。
摘要:
Derivatives of a tumor necrosis factor (TNF), which originate from a modification at the amino terminus of the TNF molecule are suitable for controlling diseases.
摘要:
Polypeptides which differ from lymphotoxin by the absence of amino acids at the N-terminal end of the lymphotoxin are described. The polypeptides can be prepared by gene manipulation and are suitable, alone or in combination with lymphokines, as pharmaceuticals.
摘要:
The invention relates to the use of TNF antagonists for producing drugs for the treatment of disorders characterized by elevated serum levels of interleukin-6.